These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 6329666)
21. Renal effects of native parathyroid hormone and synthetic biologically active fragments in pseudohypoparathyroidism and hypoparathyroidism. Neer RM; Tregear GW; Potts JT J Clin Endocrinol Metab; 1977 Feb; 44(2):420-3. PubMed ID: 190258 [TBL] [Abstract][Full Text] [Related]
22. [The effects of synthetic 1-34 fragment of human PTH on kidney and bone receptors in man. Use of the Ellsworth-Howard test]. Audran M; Alix E; Jallet P; Renier JC Rev Rhum Mal Osteoartic; 1982; 49(8-9):599-608. PubMed ID: 6314480 [TBL] [Abstract][Full Text] [Related]
23. [Parathyroid insufficiency syndrome. Two new cases: type Ia pseudohypoparathyroidism and pseudo-idiopathic hypoparathyroidism]. Barajas de Frutos D; Pedrero Vera J; Bolívar Barrales JE; Espigares Martín R; Ortega Martos L; Vílchez Joya R; Bolívar Galiano V; Morell Bernabé JJ An Esp Pediatr; 1989 Oct; 31(4):385-8. PubMed ID: 2560613 [TBL] [Abstract][Full Text] [Related]
24. Rapid development of renal resistance to low doses of synthetic bovine parathyroid hormone fragment 1-34. Dissociation of urinary cyclic adenosine monophosphate, phosphaturic, and calciuric responses. Law WM; Heath H J Clin Invest; 1983 Sep; 72(3):1106-13. PubMed ID: 6309905 [TBL] [Abstract][Full Text] [Related]
25. [The usefulness of the teriparatide acetate (Parathar) infusion test in the diagnosis of pseudohypoparathyroidism]. Rius F; Salinas I; Reverter JL; Pizarro E; Lucas A Med Clin (Barc); 1993 Sep; 101(8):303-5. PubMed ID: 8397330 [TBL] [Abstract][Full Text] [Related]
26. [Pseudohypoparathyroidism: investigations of the serum parathyroid hormone level, pte resistance and urinary camp excretion before and during vitamin d treatment (author's transl)]. Stögmann W Wien Klin Wochenschr Suppl; 1975; 33():1-15. PubMed ID: 176830 [TBL] [Abstract][Full Text] [Related]
27. Effects of parathyroid hormone and calcitonin on plasma and nephrogenous cyclic adenosine-3',5'-monophosphate in normal subjects and in pathological conditions. Caniggia A; Gennari C; Lore F; Nuti R; Galli M Eur J Clin Invest; 1980 Apr; 10(2 Pt 1):99-105. PubMed ID: 6257524 [TBL] [Abstract][Full Text] [Related]
28. A comparison of the in vivo biochemical responses to exogenous parathyroid hormone-(1-34) [PTH-(1-34)] and PTH-related peptide-(1-34) in man. Fraher LJ; Hodsman AB; Jonas K; Saunders D; Rose CI; Henderson JE; Hendy GN; Goltzman D J Clin Endocrinol Metab; 1992 Aug; 75(2):417-23. PubMed ID: 1322424 [TBL] [Abstract][Full Text] [Related]
29. Effects of parathyroid hormone and the synthetic 1-34 amino-terminal fragment in rats and dogs. Stevenson RW; Parsons JA J Endocrinol; 1983 Apr; 97(1):21-30. PubMed ID: 6842124 [TBL] [Abstract][Full Text] [Related]
30. Human PTH(1-34) infusion test in differential diagnosis of various types of hypoparathyroidism: an attempt to establish a standard clinical test. Yamamoto M; Furukawa Y; Konagaya Y; Sohn HE; Tomita A; Fujita T; Ogata E Bone Miner; 1989 May; 6(2):199-212. PubMed ID: 2548645 [TBL] [Abstract][Full Text] [Related]
31. 1,25-Dihydroxyvitamin D production after stimulation with synthetic human parathyroid hormone (1-34) in hypoparathyroid and renal tubular disorders. Yasuda T; Nakajima H Endocrinol Jpn; 1984 Aug; 31(4):407-15. PubMed ID: 6097438 [TBL] [Abstract][Full Text] [Related]
32. Parathyroid hormone (PTH)-related protein(1-36) is equipotent to PTH(1-34) in humans. Everhart-Caye M; Inzucchi SE; Guinness-Henry J; Mitnick MA; Stewart AF J Clin Endocrinol Metab; 1996 Jan; 81(1):199-208. PubMed ID: 8550752 [TBL] [Abstract][Full Text] [Related]
33. A 6-hour human parathyroid hormone (1-34) infusion protocol: studies in normal and hypoparathyroid subjects. McElduff A; Lissner D; Wilkinson M; Cornish C; Posen S Calcif Tissue Int; 1987 Nov; 41(5):267-73. PubMed ID: 2825934 [TBL] [Abstract][Full Text] [Related]
34. [Case of pseudohypoparathyroidism type 1b diagnosed as having hypocalcemia]. Iida S Clin Calcium; 2005 Apr; 15(4):689-93. PubMed ID: 15802786 [TBL] [Abstract][Full Text] [Related]
35. Parathyroid hormone infusion test in children and adolescents. Hochberg Z; Moses AM; Richman RA Miner Electrolyte Metab; 1984; 10(2):113-6. PubMed ID: 6321936 [TBL] [Abstract][Full Text] [Related]
37. [Current function tests in hypoparathyroidism in children]. Mallet E; Gugi B; Basuyau JP Ann Endocrinol (Paris); 1983; 44(4):235-8. PubMed ID: 6322667 [TBL] [Abstract][Full Text] [Related]
38. A simplified assessment of response to parathyroid hormone in hypoparathyroid patients. Tomlinson S; Hendy GN; O'Riordan JH Lancet; 1976 Jan; 1(7950):62-4. PubMed ID: 54582 [TBL] [Abstract][Full Text] [Related]
39. Renal 1,25-dihydroxyvitamin D, phosphaturic, and cyclic-AMP responses to intravenous synthetic human parathyroid hormone-(1-34) administration in normal subjects. Slovik DM; Daly MA; Potts JT; Neer RM Clin Endocrinol (Oxf); 1984 Apr; 20(4):369-75. PubMed ID: 6325049 [TBL] [Abstract][Full Text] [Related]
40. [Cumulative result of Ellsworth-Howard test using synthetic 1-34 human parathyroid hormone]. Yamamoto M; Igarashi T; Takuwa Y; Furukawa Y; Fujita T Horumon To Rinsho; 1983 Aug; 31(8):765-72. PubMed ID: 6627712 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]